Evidence map›Paper›PMID 32170482›Full record

ArticleClinical rheumatology2020

Correction to: Validation of a renal risk score in a cohort of ANCA-associated vasculitis patients with severe kidney damage.

Juan M Mejía-Vilet, Eduardo Martín-Nares, Mayra L Cano-Verduzco, Abril A Pérez-Arias, Manuel A Sedano-Montoya, Andrea Hinojosa-Azaola

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Juan M Mejía-ViletDepartment of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico, Mexico.ORCID https://orcid.org/0000-0003-4062-9412
Eduardo Martín-NaresDepartment of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Col. Sección XVI, Tlalpan, 14000, Mexico, CP, Mexico.ORCID https://orcid.org/0000-0002-7911-1269
Mayra L Cano-VerduzcoFacultad de Medicina, Universidad Autónoma de Baja California campus Mexicali, Mexicali, Mexico.ORCID https://orcid.org/0000-0003-1783-0193
Abril A Pérez-AriasFacultad de Medicina, Universidad Autónoma de Baja California campus Mexicali, Mexicali, Mexico.ORCID https://orcid.org/0000-0001-6537-3666
Manuel A Sedano-MontoyaDepartment of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Col. Sección XVI, Tlalpan, 14000, Mexico, CP, Mexico.ORCID https://orcid.org/0000-0002-0942-9167
Andrea Hinojosa-AzaolaDepartment of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Col. Sección XVI, Tlalpan, 14000, Mexico, CP, Mexico. andreaha@yahoo.com.ORCID https://orcid.org/0000-0002-4001-3995

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The footnote of Figure 2 in the published original version of the above article went missing and the correct figure is presented in this article.

Identifiers

PMID32170482

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.